Chengyong Dong
Overview
Explore the profile of Chengyong Dong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu J, Sun B, Guo K, Yang Z, Zhao Y, Gao M, et al.
Cancer Gene Ther
. 2022 Jul;
29(12):1951-1960.
PMID: 35902729
Monocytes/macrophages, a plastic and heterogeneous cell population of the tumor microenvironment (TME), can constitute a major component of most solid tumors. Under the pressure of rapid proliferation of the tumor,...
2.
Liu W, Liu X, Liu Y, Ling T, Chen D, Otkur W, et al.
Exp Cell Res
. 2022 Jun;
418(1):113244.
PMID: 35697078
PLIN2 has been found to be dysregulated in several human malignancies, which influences cancer progression. However, the roles of PLIN2 in regulating hepatocellular carcinoma (HCC) progression are still unclear. Here,...
3.
Wang H, Dong C, Jiang K, Zhang S, Long F, Zhang R, et al.
RSC Adv
. 2022 May;
8(2):994-1000.
PMID: 35538969
Hepatocellular carcinoma (HCC) is the major subtype of primary liver cancer. Although the standard treatment method based on surgery has generally extended life, it still causes the second and sixth...
4.
Guo C, Li N, Dong C, Wang L, Li Z, Liu Q, et al.
J Adv Res
. 2021 May;
30:85-102.
PMID: 34026289
Introduction: As a member of annexin family proteins, annexin A3 (ANXA3) has 36-kDa and 33-kDa isoforms. ANXA3 plays crucial roles in the tumorigenesis, aggressiveness and drug-resistance of cancers. However, previous...
5.
Jiang K, Dong C, Yin Z, Li R, Mao J, Wang C, et al.
Cell Death Dis
. 2020 Nov;
11(11):972.
PMID: 33184263
Alpha-enolase (ENO1) has been found to be dysregulated in several human malignancies, including hepatocellular carcinoma (HCC). Although the role of ENO1 as a glycolytic enzyme in HCC cells has been...
6.
Li R, Dong C, Jiang K, Sun R, Zhou Y, Yin Z, et al.
Carcinogenesis
. 2020 May;
41(11):1583-1591.
PMID: 32390047
Liver cancer is a major threat to human life and health, and chemotherapy has been the standard non-surgical treatment for liver cancer. However, the emergence of drug resistance of liver...
7.
Sun R, Dong C, Li R, Chu H, Liu J, Hao D, et al.
Proteomics Clin Appl
. 2020 Feb;
14(4):e1900080.
PMID: 32067389
Purpose: The extensive drug resistance of hepatocellular carcinoma (HCC) has become a major cause of chemotherapy failure. A deeper understanding of the drug resistance mechanism of tumor cells is very...
8.
Wang X, Yin Z, Zhao Y, He M, Dong C, Zhong M
Mol Med Rep
. 2020 Feb;
21(3):1647-1657.
PMID: 32016476
The present study aimed to identify sensitive, specific and independent prognostic biomarkers in head and neck cancer (HNC) based on microRNA expression profiles and other high‑throughput sequencing data in The...
9.
Liu L, Dong C, Li X, Li S, Ma B, Zhao B, et al.
Small
. 2020 Jan;
16(7):e1904199.
PMID: 31971662
The selective and highly efficient capture of circulating tumor cells (CTCs) from blood and their subsequent release without damage are very important for the early diagnosis of tumors and for...
10.
Zhang S, Li M, Xia W, Fan J, Wang J, Li Y, et al.
Anal Chem
. 2019 Oct;
91(21):13501-13507.
PMID: 31571476
The Wnt pathway is dysregulated and activated in many human malignancies. More than 90% of colon cancers have variations in the Wnt pathway. Sulindac, a drug that targets protein Dvl...